Journal:
:P & T : a peer-reviewed journal for formulary management2017
Stephen Barlas
Raising their voices in nearly unanimous opposition, pharmaceutical manufacturers and their suppliers have mounted a campaign to dissuade the FDA from launching a voluntary program in 2018 that is aimed at reducing drug shortages.
